Company’s year-end TULSA-PRO installed base stood at 78 systems; qualified sales pipeline grew to 97 new systemsTORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ...

Are they profound wisdom? Or are they bull? If you thought they were profound, you might need your BS detector checked. Created from the website wisdomofchopra.com, this “wisdom” was generated by ...

Tech Edge hosted a fireside chat on August 12 at Nasdaq MarketSite with Erik Carlson, President and Chief Executive Officer at Notified and James Cadwallader, Chief Executive Officer and Co-founder of ...

CEO Arun Menawat highlighted the CAPTAIN trial results presented at the American Urological Association Meeting, describing them as establishing TULSA's statistical superiority over robotic radical ...

As AI chatbots like ChatGPT and Perplexity reshape how people search—siphoning queries away from Google—startups are racing to help brands stay visible in AI-generated responses. Profound, which ...

Profound Medical Corp. remains rated Sell due to persistent competitive pressures, missed growth promises, and deteriorating financials. PROF's recent 20% stock spike followed news of a Dallas Medical ...

Arun Menawat, CEO of Profound Medical, talks about the company’s innovative TULSA-PRO technology. In a recent interview, Arun Menawat, CEO of Profound Medical, discussed the company’s innovative TULSA ...

PROF is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of PROF shares has increased $0.21 since the market last closed. This is a 2.49% ...

"What do you take me for, an idiot?" —Charles de Gaulle, when a journalist asked him if he was happy "My wife and I were happy for 20 years. Then we met!" —Rodney Dangerfield We can distinguish ...

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (Nasdaq:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the sale of 5,142,857 common shares at a purchase price of $7.00 ...